OPK
Opko Health Inc
NASDAQ: OPK · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1.12
-1.37% today
Updated 2026-06-05
Market cap
$1.06B
P/E ratio
—
P/S ratio
1.82x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$1 – $2
Volume
2.5M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F6.0
Quality
B2.0
Profitability
F4.0
Valuation
C3/9
Piotroski F-Score
Weak
-0.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$3.76
+235.71%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy2 Buy3 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.33x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -0.30 — distress zone
- Thin margins at -36.60%
- Negative free cash flow $-21.14M
- Revenue declining -17.20% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.00B | $863.50M | $713.14M | $606.88M | $581.12M |
| Net income | $-328.40M | $-188.86M | $-53.22M | $-225.68M | $-54.85M |
| EPS | — | — | — | — | $-0.27 |
| Free cash flow | $-119.77M | $-44.47M | $-208.50M | $-190.82M | $-21.14M |
| Profit margin | -32.70% | -21.87% | -7.46% | -37.19% | -36.60% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-20 | PAGANELLI, JOHN A | Buy | 10,000 | $1.14 |
| 2026-03-18 | UPPALURI, SUBBARAO V | Buy | 50,000 | — |
| 2025-11-21 | FROST, PHILLIP MD ET AL | Buy | 192,870 | $1.34 |
Peer comparison
Smart narrative
Opko Health Inc trades at $1.12. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -0.30, it sits in the distress. TTM revenue stands at $581.12M. with profit margins at -36.60%.
Frequently asked questions
What is Opko Health Inc's stock price?
Opko Health Inc (OPK) trades at $1.12, on a P/S of 1.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Opko Health Inc overvalued?
Opko Health Inc carries a Smart Value Score of 31/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Opko Health Inc (OPK)?
The 12-month analyst consensus target is $3.76, about 235.7% above the current $1.12. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Opko Health Inc's revenue?
Opko Health Inc's trailing twelve-month revenue is $581.12M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Opko Health Inc's Altman Z-Score is -0.30, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.82x
ROE-17.68%
Beta1.41
50D MA$1.18
200D MA$1.30
Shares out0.76B
Float0.33B
Short ratio—
Avg volume2.5M
Performance
1 week+13.18%
1 month+32.73%
3 months+22.69%
YTD+15.87%
1 year—
3 years—
5 years—